Sublingual immunotherapy and oral mucosal langerhans cells

Immunotherapy

Volumn 3, Issue 1, 2011, Pages 9-10

  Blázquez, Ana Belén ^a   Mayorga, Cristobalina ^a   Blanca López, Natalia ^b   Jaén, Maria José Torres ^c  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOMODULATING AGENT;

ALLERGIC RHINITIS; ASTHMA; CELL MATURATION; CELL MIGRATION; CELL POPULATION; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; LANGERHANS CELL; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 78650538186     PISSN: 1750743X     EISSN: None     Source Type: Journal    
DOI: 10.2217/imt.10.98     Document Type: Note

References (6)

1. Bagnasco M, Altrinetti V, Pesce G et al.: Pharmacokinetics of Der p 2 allergen and derived monomeric allergoid in allergic volunteers. Int. Arch. Allergy Immunol. 138, 197-202 (2005). (Pubitemid 41540677)
2. Allam JP, Niederhagen B, Bücheler M et al.: Comparative analysis of nasal and oral mucosa dendritic cells. Allergy 61, 166-172 (2006). (Pubitemid 43381825)
3. Allam JP, Würtzen PA, Reinartz M et al.: Phl p 5 resorption in human oral mucosa leads to dose-dependent and time-dependent allergen binding by oral mucosal Langerhans cells, attenuates their maturation, and enhances their migratory and TGF-β1 and IL-10-producing properties. J. Allergy Clin. Immunol. 126, 638-645 (2010).
4. Steinman RM, Hawiger D, Nussenzweig MC: Tolerogenic dendritic cells. Annu. Rev. Immunol. 21, 685-711 (2003). (Pubitemid 37174545)
5. +T cell responses elicited by different subsets of human skin migratory dendritic cells. J. Immunol. 175, 7905-7915 (2005). (Pubitemid 41798351)
6. Novak N, Haberstok J, Bieber T, Allam JP: The immune privilege of the oral mucosa. Trends Mol. Med. 14, 191-198 (2008).